Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 450621, 8 pages
http://dx.doi.org/10.1155/2014/450621
Research Article

RNA Sequencing Reveals Upregulation of RUNX1-RUNX1T1 Gene Signatures in Clear Cell Renal Cell Carcinoma

1Department of Urology, Huashan Hospital, Fudan University, 12 Central Urumqi Road, Shanghai 200040, China
2Fudan-VARI Center for Genetic Epidemiology, School of Life Sciences, Fudan University, Shanghai 200433, China
3Laboratory of Bioinformatics, Center for Genetic Epidemiology and Prevention, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
4Center for Cancer Genomics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
5Laboratory of Computational, Laboratory of Genomics and Prevention, Center for Genetic Epidemiology and Prevention, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA

Received 12 November 2013; Revised 21 January 2014; Accepted 31 January 2014; Published 25 March 2014

Academic Editor: Gary S. Stein

Copyright © 2014 Zuquan Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. T. Cohen and F. J. McGovern, “Renal-cell carcinoma,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2477–2490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Takahashi, X. J. Yang, J. Sugimura et al., “Molecular subclassification of kidney tumors and the discovery of new diagnostic markers,” Oncogene, vol. 22, pp. 6810–6818, 2003. View at Publisher · View at Google Scholar
  4. K. A. Furge, K. A. Lucas, M. Takahashi et al., “Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles,” Cancer Research, vol. 64, no. 12, pp. 4117–4121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. A. Furge, J. Chen, J. Koeman et al., “Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma,” Cancer Research, vol. 67, no. 7, pp. 3171–3176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Ding, D. Huang, Z. Zhang et al., “Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets,” Cancer Research, vol. 71, pp. 5225–5234, 2011. View at Publisher · View at Google Scholar
  7. M. Sultan, M. H. Schulz, H. Richard et al., “A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome,” Science, vol. 321, pp. 956–960, 2008. View at Publisher · View at Google Scholar
  8. I. Chepelev, G. Wei, Q. Tang, and K. Zhao, “Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq,” Nucleic Acids Research, vol. 37, no. 16, Article ID e106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, and B. Wold, “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nature Methods, vol. 5, no. 7, pp. 621–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Greif, S. H. Eck, N. P. Konstandin et al., “Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing,” Leukemia, vol. 25, no. 5, pp. 821–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. G. R. Grant, M. H. Farkas, A. D. Pizarro et al., “Comparative analysis of RNA-Seq alignment algorithms and the RNA-Seq unified mapper (RUM),” Bioinformatics, vol. 27, no. 18, Article ID btr427, pp. 2518–2528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Langmead, C. Trapnell, M. Pop, and S. L. Salzberg, “Ultrafast and memory-efficient alignment of short DNA sequences to the human genome,” Genome Biology, vol. 10, no. 3, article R25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Li, B. Handsaker, A. Wysoker et al., “The sequence alignment/map format and SAMtools,” Bioinformatics, vol. 25, pp. 2078–2079, 2009. View at Publisher · View at Google Scholar
  14. M. Garber, M. G. Grabherr, M. Guttman, and C. Trapnell, “Computational methods for transcriptome annotation and quantification using RNA-seq,” Nature Methods, vol. 8, no. 6, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Anders and W. Huber, “Differential expression analysis for sequence count data,” Genome Biology, vol. 11, no. 10, article R106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Furge, K. J. Dykema, C. Ho, and X. Chen, “Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma,” BMC Genomics, vol. 6, article 67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Klomp, D. Petillo, N. M. Niemi et al., “Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression,” BMC Med Genomics, vol. 3, article 59. View at Publisher · View at Google Scholar
  18. J. P. MacKeigan, L. O. Murphy, and J. Blenis, “Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance,” Nature Cell Biology, vol. 7, no. 6, pp. 591–600, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Lopez-Jimenez, G. Gómez-López, L. J. Leandro-García et al., “Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas,” Molecular Endocrinology, vol. 24, no. 12, pp. 2382–2391, 2010. View at Publisher · View at Google Scholar
  20. O. Aprelikova, G. V. R. Chandramouli, M. Wood et al., “Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors,” Journal of Cellular Biochemistry, vol. 92, no. 3, pp. 491–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Grabmaier, J. L. Vissers, M. C. de Weijert et al., “Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250,” International Journal of Cancer, vol. 85, pp. 865–870, 2000. View at Google Scholar
  22. E. Oosterwijk, D. J. Ruiter, and J. Hoedemaeker, “Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney,” International Journal of Cancer, vol. 38, no. 4, pp. 489–494, 1986. View at Google Scholar · View at Scopus
  23. G. Siemeister, K. Weindel, K. Mohrs, B. Barleon, G. Martiny-Baron, and D. Marmé, “Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein,” Cancer Research, vol. 56, no. 10, pp. 2299–2301, 1996. View at Google Scholar · View at Scopus
  24. O. Iliopoulos, A. P. Levy, C. Jiang, W. G. Kaelin Jr., and M. A. Goldberg, “Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 20, pp. 10595–10599, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Giebisch, “Renal potassium transport: Mechanisms and regulation,” The American Journal of Physiology—Renal Physiology, vol. 274, no. 5, pp. F817–F833, 1998. View at Google Scholar · View at Scopus
  26. E. J. Kort, L. Farber, M. Tretiakova et al., “The E2F3-oncomir-1 axis is activated in Wilms' tumor,” Cancer Research, vol. 68, no. 11, pp. 4034–4038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Tonks, L. Pearn, M. Musson et al., “Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia,” Leukemia, vol. 21, no. 12, pp. 2495–2505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. F. Peterson and D. E. Zhang, “The 8;21 translocation in leukemogenesis,” Oncogene, vol. 23, no. 24, pp. 4255–4262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Yagoda, B. Abi-Rached, and D. Petrylak, “Chemotherapy for advanced renal-cell carcinoma: 1983–1993,” Seminars in Oncology, vol. 22, no. 1, pp. 42–60, 1995. View at Google Scholar · View at Scopus
  30. A. T. Fojo, D.-W. Shen, L. A. Mickley, I. Pastan, and M. M. Gottesman, “Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene,” Journal of Clinical Oncology, vol. 5, no. 12, pp. 1922–1927, 1987. View at Google Scholar · View at Scopus
  31. D. P. Guimaraes, I. M. Oliveira, E. de Moraes et al., “Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas,” International Journal of Cancer, vol. 124, no. 2, pp. 272–279, 2009. View at Publisher · View at Google Scholar
  32. “Comprehensive molecular characterization of clear cell renal cell carcinoma,” Nature, vol. 499, no. 7456, pp. 43–49, 2013. View at Publisher · View at Google Scholar